Stuart Finnie

Stuart Finnie is currently the Senior Director of CMC Regulatory Affairs at Gilead Sciences, focusing on CMC RA policy, advocacy, and intelligence. They have held various regulatory roles, including Director of Regulatory CMC at AstraZeneca from 2015 to 2022 and Regulatory Affairs Manager at Cardinal Health and Omnicare Clinical Research earlier in their career. Finnie earned a BSc from The University of Edinburgh, an MSc from the University of Aberdeen, and a PhD from the University of Strathclyde.